Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 5;37(8):1682-1697.e6.
doi: 10.1016/j.cmet.2025.04.013. Epub 2025 May 16.

Acetylated cellulose suppresses body mass gain through gut commensals consuming host-accessible carbohydrates

Affiliations
Free article

Acetylated cellulose suppresses body mass gain through gut commensals consuming host-accessible carbohydrates

Tadashi Takeuchi et al. Cell Metab. .
Free article

Abstract

Effective approaches to preventing and treating obesity are urgently needed. Although current strategies primarily focus on direct modulation of host metabolism, another promising approach may involve limiting nutrient availability through regulation of the gut microbiota, which links diet and host physiology. Here, we report that acetylated cellulose (AceCel), which markedly alters gut bacterial composition and function, reduces body mass gain in both wild-type and obese mice. AceCel limits carbohydrate oxidation and promotes fatty acid oxidation in the host liver in a microbiota-dependent manner. We further show that acetate enhances carbohydrate fermentation by the gut commensal Bacteroides thetaiotaomicron, depleting host-accessible simple sugars in the gut of AceCel-fed mice. These findings highlight the potential of AceCel as a prebiotic that regulates carbohydrate metabolism in both bacteria and host, offering promise as a therapeutic strategy for obesity.

Keywords: bacterial metabolism; gut microbiota; obesity; prebiotics; short-chain fatty acid.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests S.S. and A.M. are employees of Daicel Corporation. This study is supported in part by a research fund from Daicel Corporation. S.S. is one of the co-inventors on a patent application related to this work (WO 2015/093067 A1, March 2014). The current affiliations for T.T., Y.N., and Y.I. are Stanford University, Riken Genesis Co., Ltd., and Wakamoto Pharmaceutical Co., Ltd., respectively.

LinkOut - more resources